ONCOFACTOR CORP

Profile

Company Names

ONCOFACTOR CORP

Addresses

1616 EASTLAKE AVE E, SUITE 200, SEATTLE, WA 98102

Phone Numbers

(206) 957-7300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$3,100,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-08-22 
$1,000,000.00 
$6,000,000.00 
$5,000,000.00 
Equity 
1
2011-05-05 
$2,100,000.00 
$5,100,000.00 
$3,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEE 
 
BABISS 
DIRECTOR
B3 BIO, INC.   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  X-RX, INC.   |  MODERNA LLC   |  MODERNA THERAPEUTICS, INC.
STEVE 
 
GILLIS 
DIRECTOR
XORI CORP   |  ONCOFACTOR CORP   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.   |  ONCORESPONSE INC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VBI VACCINES INC/BC   |  ALLY THERAPEUTICS, INC.   |  SKYLARK BIO, INC.   |  BASKING BIOSCIENCES, INC.
THONG 
 
LE 
DIRECTOR
XORI CORP   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  QAZZOW, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
DAVID 
 
MCELLIGOTT 
EXECUTIVE OFFICER
ONCOFACTOR CORP   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.
JANIS 
 
NAEVE 
DIRECTOR
RELYPSA INC   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  NEXIMMUNE, INC.
LINDSAY 
 
RAYLE 
EXECUTIVE OFFICER
XORI CORP   |  MIRINA CORP   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  ACYLIN THERAPEUTICS, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP
DAVID 
 
SCHUBERT 
EXECUTIVE OFFICER
XORI CORP   |  MIRINA CORP   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP
CHAD 
 
WAITE 
DIRECTOR
PLECTIX BIOSYSTEMS INC   |  ADAPX INC   |  XORI CORP   |  LIMERICK BIOPHARMA INC   |  VERDEZYNE INC   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  AGGREGATE KNOWLEDGE INC   |  SYMFORM, INC.   |  CYRUS BIOTECHNOLOGY, INC.   |  TWINSTRAND BIOSCIENCES, INC.
CARL 
 
WEISSMAN 
EXECUTIVE OFFICER, DIRECTOR
XORI CORP   |  NOVOMER INC   |  FATE THERAPEUTICS INC   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  ALLOZYNE INC   |  VIRAL LOGIC SYSTEMS TECHNOLOGY CORP   |  MATRIX GENETICS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-22 
2011-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE